All In Biotech

NDA 020589 · Haleon US Holdings

Children'S Advil-Flavored

Ibuprofen · Oral · Nonsteroidal Anti-inflammatory Drug

Last checked: Nov 20, 2026Latest source record: Jun 26, 2026 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations

First approved

1996

Jun 27, 1996

Approved uses

1

Original approval plus efficacy supplements

Registered trials

910

162 Phase 3, 61 recruiting

FAERS reports

202,330

147,001 serious, 16,467 with death reported

AI brief across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.

What it is approved for

From the label in effect Feb 8, 2024.

USES temporarily: • reduces fever • relieves minor aches and pains due to the common cold, flu, sore throat, headaches and toothaches

Therapeutic areas: Pain and anesthesia

Approval history

Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.

  • Jun 27, 1996 Original approval · Type 8 - Partial Rx to OTC Switch
2 products under this application
  • CHILDREN'S ADVIL-FLAVORED · IBUPROFEN 100MG/5ML · SUSPENSION, ORAL · Over-the-counter
  • CHILDREN'S ADVIL · IBUPROFEN 100MG/5ML · SUSPENSION, ORAL · Over-the-counter

Clinical trials

Interventional ClinicalTrials.gov studies with "Ibuprofen" as an intervention, any sponsor and status, largest first.

All 910 trials

Most reported adverse reactions

FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.

Signals
  • drug ineffective16,112
  • pain15,231
  • fatigue14,710
  • nausea13,744
  • headache12,260
  • arthralgia11,071
  • dyspnoea10,679
  • vomiting10,236
  • diarrhoea9,855
  • rash9,201
  • off label use8,779
  • dizziness8,308

FAERS reports by year

By the date FDA received the report.

View as table
YearReports
20041,686
20052,203
20062,065
20072,115
20081,785
20092,765
20104,017
20115,784
20127,182
20136,873
20146,655
20159,240
201612,662
201711,398
201815,640
201916,701
202015,491
202115,272
202214,655
202313,694
202412,663
202512,816
20268,959

Recalls

1 FDA enforcement reports for this application.

  • Aug 23, 2018 · Class II · Terminated

    Labeling Error: Not elsewhere classified. product has a dosage cup marked in teaspoons and the instructions on the label are described in milliliters.

Shortages

FDA's drug shortage list.

Not on FDA's shortage list.

Medicare spending

CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.

Compare

Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.

Published evidence

PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.

All 2,679 on PubMed

Sponsor: Haleon US Holdings · Also marketed as Children'S Advil

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.